Biotechnology company OncoSec Medical Inc. in Pennington appointed Robert Arch as president and chief executive officer. Arch was previously head of research at Elpiscience Biopharma Ltd. from October ...
SAN DIEGO and NEW JERSEY, Oct. 29, 2018 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced the appointment ...
Following a shake-up at the top, OncoSec Medical is now reducing its workforce by almost half as it tightens its focus on its lead melanoma trial of its only clinical-stage candidate. Between December ...
PENNINGTON, N.J. and SAN DIEGO, Aug. 16, 2021 /PRNewswire/ — OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”) today announced the establishment of a Leadership Committee ...
SAN DIEGO and PENNINGTON, N.J., Nov. 8, 2018 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced the ...
SAN DIEGO & PENNINGTON, N.J.--(BUSINESS WIRE)--OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today ...
PENNINGTON, N.J. and SAN DIEGO, May 23, 2022 /PRNewswire/ -- OncoSec Medical Incorporated (ONCS) (the "Company" or "OncoSec") today announced that it is the recipient of the 2022 Vanguard Award ...
OncoSec has built a deep and diverse clinical pipeline utilizing TAVO as a potential treatment for multiple cancer indications either as a monotherapy or in combination with leading checkpoint ...
PENNINGTON, N.J. and SAN DIEGO, April 29, 2022 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company focused on developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results